MedTrace Logo

Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders

NCT01438385 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 12000

Last updated 2017-02-20

No results posted yet for this study

Summary

Our institution performs therapeutic ERCP (Endoscopic retrograde cholangiopancreatography ), Endoscopic Ultrasound (EUS) and Interventional Endoscopy in around 1000 patients a year. Procedures such as biliary and/or pancreatic sphincterotomy, stents placement (metallic or plastic) and removal for revision, cysts and pseudocysts drainage are conducted in patients suffering from pancreatico-biliary disorders, gastrointestinal disorders and esophageal disorders. The investigators would like to assess prospectively the efficacy and safety of these routine procedures to permit identification of technical details about the procedures or other factors which might be associated with outcome or results. Assessment of these details would help us with problem identification and recommendations to improve health outcomes and quality of life in these patients.

Conditions

  • Ampullary Cancer
  • Duodenal Cancer
  • Bile Duct Cancer
  • Bile Duct Disorders
  • Gallstones
  • Obstructive Jaundice
  • Pancreatic Disorders (Noncancerous)
  • Colorectal Cancer
  • Esophageal Cancer
  • Barrett's Esophagus
  • Gastric Malignancies
  • Pancreatic Cancer
  • Pediatric Gastroenterology
  • Cholangiocarcinoma
  • Pancreatic Pseudocysts
  • Acute and Chronic Pancreatitis
  • Recurrent Pancreatitis
  • Cholangitis
  • Bile Leak
  • Biliary Strictures
  • Pancreatic Divisum
  • Biliary and Pancreatic Stones
  • Choledocholithiasis

Interventions

PROCEDURE

Interventional Endoscopy

Advanced imaging endoscopic or therapeutic endoscopy

Sponsors & Collaborators

  • Weill Medical College of Cornell University

    lead OTHER

Principal Investigators

  • Michel Kahaleh, MD · Weill Medical College of Cornell University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2017-12-30
Completion
2017-12-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01438385 on ClinicalTrials.gov